MedPath

A randomized Controlled trial of the Case management to Encourage participation in cancer Screening for people with Schizophrenia in psychiatric outpatient clinics

Phase 3
Conditions
Schizophrenia (including Schizoaffective disorder)
Registration Number
JPRN-UMIN000036017
Lead Sponsor
Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science
Brief Summary

Please see the above paper

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
172
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with a history of colorectal cancer 2) Patients who have already participated in colorectal cancer screening in the 2018 fiscal year 3) Patients who plan to move out of Okayama city within 6 months 4) Patients who lived in an institution where residents are supported for receiving cancer screenings 5) Patients who are judged by their primary psychiatrists as having a risk to deteriorate their symptoms by participating the study 6) Patients who are judged as having insufficient ability to judge by their primary psychiatrist, and who are not accompanied by their proxies in visiting clinics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of the participants who received municipal colorectal cancer screening in the fiscal year 2019
Secondary Outcome Measures
NameTimeMethod
The proportion of the participants who received other municipal cancer screenings in the fiscal year 2019 which are recommended for participants Reasons of participation or non-participation in colorectal cancer screening and detailed examination recommended after screening Participant's comments on receiving the intervention and useful elements of the intervention Case manager's comments on useful elements and practical issues of the intervention Required time for the intervention
© Copyright 2025. All Rights Reserved by MedPath